Related Experiment Video

Updated: Jun 2, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Physician adherence to the dyslipidemia guidelines is as challenging an issue as patient adherence

Geva Vashitz1, Joachim Meyer, Yisrael Parmet

  • 1Ben-Gurion University of the Negev.

Family Practice
|May 14, 2011
PubMed

Insights

Physician non-adherence hinders guideline practice for dyslipidemia secondary prevention. Patient adherence is higher, but initiating pharmacotherapy remains challenging for physicians, especially in high-volume settings.

Area of Science:

  • Cardiology
  • Primary Care Medicine
  • Health Services Research

Background:

  • A significant gap exists between evidence-based guidelines and primary care practice for dyslipidemia secondary prevention.
  • Physician and patient adherence are key factors contributing to this therapeutic gap.

Purpose of the Study:

  • To differentiate physician and patient adherence to dyslipidemia secondary prevention guidelines.
  • To identify factors influencing adherence in a primary care setting.

Main Methods:

  • Post hoc analysis of a prospective cluster randomized trial involving 7041 patients and 127 physicians over 18 months.
  • Adherence measured by physician and patient actions; correlated using multivariate logistic regressions.

Main Results:

  • Physician adherence rates were low: 36.9% for lipid screening, 27.6% for pharmacotherapy up-titration, and 21.0% for initiation.
  • Physician adherence correlated with frequent patient visits and higher numbers of dyslipidemic patients.
  • Patient adherence was higher (83.8% for medication up-titration) but varied by guideline aspect; influenced by clinic volume, age, and physician gender.

Conclusions:

  • Physician non-adherence is a primary barrier to guideline implementation in dyslipidemia secondary prevention.
  • Pharmacotherapy initiation presents the greatest adherence challenge for physicians.
  • High-volume settings (more patients, frequent visits) are associated with greater adherence; focus on specialized clinics and frequent follow-ups is recommended.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...